Citigroup
VOR icon

Citigroup’s Vor Biopharma VOR Stock Holding History

Citigroup’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16M Buy
63,130
+57,757
+1,075% +$874K ﹤0.01% 3332
2026
Q1 		$95.9K Sell
5,373
-967
-15% -$13.6K ﹤0.01% 4301
2025
Q4 		$82.9K Buy
+6,340
New +$118K ﹤0.01% 4399
2025
Q3 		– Sell
-4,374
Closed -$142K – 6343
2025
Q2 		$142K Buy
+4,374
New +$38.7K ﹤0.01% 4239
2025
Q1 		– Hold
0
– -$7 – 6001
2024
Q4 		– Hold
0
– – – 5779
2024
Q3 		– Sell
-323
Closed -$6.46K – 5809
2024
Q2 		$6.46K Sell
323
-53
-14% -$1.71K ﹤0.01% 5221
2024
Q1 		$17.8K Buy
376
+89
+31% +$3.91K ﹤0.01% 5068
2023
Q4 		$12.9K Buy
287
+286
+28,600% +$11.8K ﹤0.01% 5132
2023
Q3 		$38 Sell
1
-1,472
-100% -$79.8K ﹤0.01% 5547
2023
Q2 		$91.1K Sell
1,473
-2,873
-66% -$262K ﹤0.01% 4293
2023
Q1 		$468K Buy
4,346
+2,269
+109% +$251K ﹤0.01% 3170
2022
Q4 		$276K Buy
2,077
+2,055
+9,341% +$203K ﹤0.01% 3559
2022
Q3 		$2K Sell
22
-16
-42% -$1.57K ﹤0.01% 5543
2022
Q2 		$4K Sell
38
-83
-69% -$8.49K ﹤0.01% 5722
2022
Q1 		$15K Sell
121
-211
-64% -$35.9K ﹤0.01% 5336
2021
Q4 		$77K Buy
332
+224
+207% +$64.6K ﹤0.01% 4864
2021
Q3 		$34K Buy
108
+81
+300% +$24.1K ﹤0.01% 4969
2021
Q2 		$10K Sell
27
-11
-29% -$5.43K ﹤0.01% 5676
2021
Q1 		$33K Buy
+38
New +$32.2K ﹤0.01% 4952

Other funds holding VOR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
AI
Axiom Investors Greenwich, Connecticut $11.6B AUM 69.67% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Citigroup's VOR Position: Q2 2026 in Review

Citigroup increased its Vor Biopharma (VOR) stake by 1,075% in Q2 2026, buying an estimated $874K and bringing the position to 63,130 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #3332.

Citigroup first reported a position in VOR in Q1 2021 and has held it in 18 quarters since. 39 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

  • Citigroup held 63,130 shares of Vor Biopharma worth $1.16M as of Q2 2026.
  • Citigroup bought 57,757 Vor Biopharma shares in Q2 2026, an estimated $874K.
  • Vor Biopharma made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3332 holding.
  • Citigroup first reported a position in Vor Biopharma in Q1 2021 and has held it in 18 quarters since.
  • 39 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.